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Bringing in the Green
Pharma stands to win hearts, minds, and tax
credits by launching an eco bandwagon
Green mind -set ca n lead to
a black bottom line. Becoming
nviron mentall y friendly ca n
help boost bra nd image a nd ROi a nd pharma ca n get there w ith a few
easy steps.
First, with about 90,000 sales representatives on the road, th e industry
could lead a revolution in tra nsportation if it bought hybrid ca rs. By replacing the current fleet, the benefits would
be substantial. Each hybrid is cheaper to
maintain, more fuel-efficient, and leaves
a far smaller greenhouse-gas footprint
on the environment. Imagine extrapolating these benefits to thousa nds of ca rs:
That's an environmentally friendly signature that shows leadership in the onearmosphere world we live in.
One promising indication is that at
least two pharmaceutical compa nies are
already providing incentives fo r their
sales consultants to order hybrids once
the leases on their current cars run out.
Tha nks to the Energy Policy Ac t of
2005, pharma could even reap a ta x
credit fo r buying hybrid ca rs in bulk.
Under that law, the governm ent has
begun awarding groundbrea king tax
incentives to consumers and businesses
that bu y or lease new hybrid ca rs. The
federal inco me tax credit ranges from
$250 to $3,400, depending o n the fuel
economy a nd the weight of the vehicle.
Additionall y, hybrid ma nu fac turers
might give pharmaceutica l companies
a di scount fo r such bulk purchases.
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Lastl y, eco-conscious doctors and co nsumers could be more inclined to buy
from compa nies that lead the cha rge on
buying hybrids.
Big Pharm a needs to create a CEO
Roundtable on the Environment, modeled after the CEO Roundtable on Ca n-

of da mage from global wa rming. Two
main threats-coral bleaching due to
rising water temperature and the acidification of surface waters due to rising
C0 2-have the potential to devastate an
already fragile ecosystem.
The second ecosystem the Roundtable
must address is the Amazon rain forest.
Seventy percent of plants found to have
anticancer properties are un ique to the
rain forest. Loss of this habitat is of serious concern for the industry. The world's
rain fo rests are already suffering the im-

An enviro-sensitive Big Pharma CEO might
decide to launch a consortium, akin to
the Roundtable on Cancer, to establish
best practices to improve the environment
ccr, an assoc iation of high-powered
CEOs (mostl y from Big Pharma) th at
seeks to forge best practices fo r a ntica ncer policies. An enviro-sensirive Big
Pharma CEO might decide to launch
such a co nso rtium to establish best
industry practices to improve the environment.
A top priority of this Roundtable
must be the preservation of major ecosystems affected by global warming.
Loss of habitat and species diversity
co uld have a direct financial impact on
pharm aceutical R&D and global health.
The great coral reefs a re a mong the
world 's most biologically diverse ecosystem s; they a nd associated orga nisms a re
a significa nt source of generic materia ls
beneficial to pha rma. These coral reefs,
already under mounting pressure from
hum an impact, a re showing clea r signs
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pact of deforestation and habitat fragmemation, and up to 50,000 species a
yea r may be lost forever. Recent droughts
and fires that reduced pa rts of the rain
forest to dry sava nn ah have highlighted
concerns over global wa rming. Such devastation serves as a clea r wa rning that
the more frequent droughts predicted by
many climate models could lead to increa sed deforestation, species extinction,
and accelerating climate change.
A commitment by Big Pha rma to
the reduction o f global CO, would be
a commitment towa rd the preservation
of these fragile ecosystems. At the sa me
time, an enha nced effo rt to preserve the
genetic potential of some of the most
vulnerable sys tems through research,
documentat ion, and a rchiving will create a va luable resource fo r the future,
when the diversity we take fo r granted
rnd ay may be a dista nt memory.
There are clear and compelling financial, corporate-citi zenship, and consumer-management arguments for the
industry to aggressively become ecofriend ly. T he first pharma company that
adopts these Green practices and ma rkets itself in this way may have a major
competiti ve advantage within reach. •
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